Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Treatment Options in Oncology|February 5, 2015
Immunotherapy for ovarian cancerJustin M Drerup, Yang Liu, Alvaro S Padron, et al.Cancer Research|October 15, 2016
Biphasic Rapamycin Effects in Lymphoma and Carcinoma TreatmentYang Liu, Srilakshmi Pandeswara, Vinh Dao, et al.Journal of Neurochemistry|August 19, 2011
Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatumMelissa I Torres-Altoro, Brian N Mathur, Justin M Drerup, et al.Journal for Immunotherapy of Cancer|January 19, 2021
Estrogen receptor beta signaling in CD8<sup>+</sup> T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switchBin Yuan, Curtis A Clark, Bogang Wu, et al.Biological Psychiatry|September 14, 2010
Attention-deficit/hyperactivity phenotype in mice lacking the cyclin-dependent kinase 5 cofactor p35Justin M Drerup, Kanehiro Hayashi, Huxing Cui, et al.Experimental Gerontology|January 13, 2018
Age effects of distinct immune checkpoint blockade treatments in a mouse melanoma modelÁlvaro Padrón, Vincent Hurez, Harshita B Gupta, et al.Cancer Research|September 19, 2020
CD122-Selective IL2 Complexes Reduce Immunosuppression, Promote Treg Fragility, and Sensitize Tumor Response to PD-L1 BlockadeJustin M Drerup, Yilun Deng, Sri Lakshmi Pandeswara, et al.Cancer Research|September 28, 2016
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and MelanomaCurtis A Clark, Harshita B Gupta, Gangadhara Sareddy, et al.Pageof 1